相关实验视频

Updated: Aug 15, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

索纳试验的后期分析:阿特拉塞坦的潜在止痛作用?

Masao Iwagami¹

¹Department of Health Services Research, Institute of Medicine, University of Tsukuba, Ibaraki, Japan; International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Ibaraki, Japan; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Kidney international

|November 19, 2023

概括

阿特拉森坦可以通过降低与疼痛相关的不良事件和止痛药的启动来减少糖尿病病患者的慢性疼痛. 需要进一步的前性试验来证实这些发现对于糖尿病病疼痛管理.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
疼痛医学医学疼痛医学
药理学药理学是指药理学的学科.

背景情况:

糖尿病病是糖尿病的常见并发症,通常与慢性疼痛有关.
糖尿病病的疼痛管理具有挑战性,有效的治疗选择有限.
阿特拉森坦是一种内甲素受体对抗剂,在治疗糖尿病病方面表现出潜在的潜力.

研究的目的:

调查阿特拉森坦对慢性疼痛相关不良事件和糖尿病脏病患者的止痛药使用的影响.
为了产生关于阿特拉森坦在这个患者群体中的潜在止痛性能的假设.

主要方法:

用阿特拉森坦 (SONAR) 试验对糖尿病病的研究进行了后期分析.
检查研究人员报告的与疼痛相关的不良事件.
在研究期间评估止痛药的开始.

主要成果:

阿特拉森坦治疗与报告的慢性疼痛相关不良事件的减少有关.
与安慰剂相比,在接受阿特拉塞坦治疗的患者中,止痛药的开始时间较低.
这项研究表明,阿特拉森坦在控制与糖尿病病相关的疼痛方面具有潜在的益处.

结论:

这些发现表明,阿特拉森坦可能有助于缓解糖尿病病患者的慢性疼痛.
限制包括疼痛数据收集的回顾性质和未知的基线疼痛状态.
需要进行前性临床试验,以验证这些初步发现并确定因果关系.

更多相关视频

Dynamic Quantitative Sensory Testing to Characterize Central Pain Processing

Dynamic Quantitative Sensory Testing to Characterize Central Pain Processing

Published on: February 16, 2017

Intracranial Pharmacotherapy and Pain Assays in Rodents

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

相关概念视频

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...